Fluconazole resistance
Fluconazole resistance in <em>Candida</em> species: a current perspective
9
Emergence of Fluconazole Resistance in a Candida parapsilosis Strain That Caused Infections in a Neonatal Intensive Care Unit
7
Clonal and Spontaneous Origins of Fluconazole Resistance in Candida albicans
7
Jjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Candida glabrata
11
MDR1 overexpression combined with ERG11 mutations induce high level fluconazole resistance in Candida tropicalis clinical isolates
6
Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis
6
Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates
12
Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy
7
Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis
17
Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis
17
Adaptive Mistranslation Accelerates the Evolution of Fluconazole Resistance and Induces Major Genomic and Gene Expression Alterations in Candida albicans
14
Susceptibility pattern of anti-candida drugs in the pediatric patients with acute leukemia
8
A Study on Speciation and Antifungal Susceptibility Pattern of Candida Isolates from HIV Patients with Oropharyngeal Candidiasis and Correlation with Cd4 Count.
100
Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients
6
A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections
6
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis
6
Replacement of Candida albicans with C dubliniensis in Human Immunodeficiency Virus Infected Patients with Oropharyngeal Candidiasis Treated with Fluconazole
5
The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan
5
An update on the application of nano-scaled carriers against fluconazole-resistant Candida species: nanostructured lipid carriers or solid lipid nanoparticles?
6
Multidrug Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method
8